Construction work on the $64m mRNA Vaccine and Biomanufacturing Center Expansion located in Charlottetown, Prince Edward Island, Canada commenced in Q2 2022. It was announced in Q1 2019.
The project involves the expansion of a 3,344m2 biopharmaceutical center in Charlottetown, Prince Edward Island, Canada.
The project includes the following:
1. Construction of an administrative building2. Construction of a cafeteria3. Construction of a logistics center4. Construction of a central power plant5. Construction of research centers6. Construction of testing centers7. Construction of storage facilities8. Construction of laboratories9. Construction of parking facilities10. Installation of machinery11. Installation of safety and security systems
Construction on the project is expected to be completed by Q4 2023.
Owners of the project include Canada-based BioVectra.
Canada-based BioVectra is the architect and engineering design consultant for the mRNA Vaccine and Biomanufacturing Center Expansion, while Charlottetown City Council is the planning authority.